January 13, 2021
View Full PaperBalancing the Risks and Benefits of Benzodiazepines
Key Points
Key points are not available for this paper at this time.
Abstract
Following a September 2020 FDA announcement of a boxed warning for benzodiazepines, this Viewpoint reviews the relative benefits and risks of the drugs to reduce overuse in at-risk patients, moderate underuse in clinically appropriate instances, and guide judicious, rational prescribing.
Cite This Study
Hirschtritt et al. (Wed,) studied this question.